ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 963,95
0,62%
Dow Jones
38 225,66
0,85%
DAX
17 984,85
0,44%
Brent Oil
83,625
-0,01%
Bitcoin
59 398,69
0,46%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Harmony Biosciences Holdings Inc (HRMY)

  7. Harmony Biosciences Holdings Inc (HRMY) Actualités

HRMY Harmony Biosciences Holdings Inc

31,69
0,00 (0,00%)
Avant marché
Dernière mise à jour : 10:00:00
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Harmony Biosciences Holdings Inc HRMY NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,00 0,00% 31,69 10:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
31,69
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
30/4/202413:05GLOBEHarmony Biosciences Reports Strong First Quarter Financial..
30/4/202413:00PRNUSHarmony Biosciences Acquires Epygenix Therapeutics, Inc.,..
16/4/202414:05PRNUSHARMONY BIOSCIENCES TO REPORT FIRST QUARTER 2024 FINANCIAL..
11/4/202414:05PRNUSHARMONY BIOSCIENCES ANNOUNCES EXCLUSIVE AGREEMENT TO DEVELOP..
03/4/202414:05PRNUSHARMONY BIOSCIENCES INITIATES GLOBAL PHASE 3 REGISTRATIONAL..
26/3/202413:05PRNUSHARMONY BIOSCIENCES TO PARTICIPATE IN 23RD ANNUAL NEEDHAM..
11/3/202422:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202422:21EDGAR2Form 144 - Report of proposed sale of securities
28/2/202423:16EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
28/2/202414:05PRNUSHARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR..
22/2/202422:14EDGAR2Form S-8 - Securities to be offered to employees in employee..
22/2/202414:00EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
22/2/202413:45EDGAR2Form 8-K - Current report
22/2/202413:30GLOBEHarmony Biosciences Reports Fourth Quarter and Full Year..
21/2/202414:05PRNUSU.S. FOOD AND DRUG ADMINISTRATION GRANTS PRIORITY REVIEW TO..
20/2/202414:05PRNUSHARMONY BIOSCIENCES RECEIVES U.S. FOOD AND DRUG..
14/2/202401:06EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/2/202414:05PRNUSHARMONY BIOSCIENCES TO REPORT FOURTH QUARTER AND FULL YEAR..
26/1/202422:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202422:58EDGAR2Form 3 - Initial statement of beneficial ownership of..
26/1/202422:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202422:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202414:30EDGAR2Form 8-K - Current report
08/1/202414:05PRNUSHARMONY BIOSCIENCES PRELIMINARY UNAUDITED FOURTH QUARTER AND..
03/1/202414:05PRNUSHARMONY BIOSCIENCES TO PRESENT AT THE 42ND ANNUAL J.P...
07/12/202322:06EDGAR2Form 8-K/A - Current report: [Amend]
07/12/202314:05PRNUSHARMONY BIOSCIENCES ANNOUNCES POSITIVE TOPLINE DATA FROM..
05/12/202314:05PRNUSHARMONY BIOSCIENCES TO PRESENT RESULTS FROM BEHAVIORAL STUDY..
16/11/202314:05PRNUSHARMONY BIOSCIENCES TO PARTICIPATE IN PIPER SANDLER 35th..
15/11/202314:05PRNUSHARMONY BIOSCIENCES RANKED AMONG TOP 25 FASTEST-GROWING..
08/11/202322:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/11/202315:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/11/202314:59EDGAR2Form 3 - Initial statement of beneficial ownership of..
08/11/202314:30EDGAR2Form 8-K - Current report
08/11/202314:05PRNUSHARMONY BIOSCIENCES APPOINTS PETER ANASTASIOU TO ITS BOARD..
31/10/202313:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
31/10/202312:45EDGAR2Form 8-K - Current report
31/10/202312:30GLOBEHarmony Biosciences Reports Strong Third Quarter 2023..
26/10/202314:05PRNUSHARMONY BIOSCIENCES SHOWCASES THE NEWEST PATIENTS AT THE..
17/10/202314:05PRNUSHARMONY BIOSCIENCES TO REPORT THIRD QUARTER 2023 FINANCIAL..
13/10/202314:15EDGAR2Form 8-K - Current report
13/10/202314:00PRNUSHARMONY BIOSCIENCES ANNOUNCES TOPLINE DATA FROM PHASE 3..
11/10/202314:15EDGAR2Form 8-K - Current report
11/10/202314:00PRNUSHARMONY BIOSCIENCES COMPLETES ACQUISITION OF ZYNERBA..
05/10/202322:15EDGAR2Form 8-K - Current report
05/10/202314:05PRNUSHARMONY BIOSCIENCES PRESENTS NEW SECONDARY OUTCOME DATA FROM..
04/10/202314:00EDGAR2Form 8-K - Current report
27/9/202314:00PRNUSHARMONY BIOSCIENCES ANNOUNCES EXTENSION OF TENDER OFFER TO..
25/9/202314:00EDGAR2Form 8-K - Current report
20/9/202314:05PRNUSHARMONY BIOSCIENCES PRESIDENT & CEO JEFFREY M. DAYNO, M.D.,..

Dernières Valeurs Consultées

NASDAQ
HRMY
Harmony Biosciences
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés